Updated:
Anthiem Ventures
Anthiem Ventures is an angel investment firm that provides funding and guidance to early-stage companies. It has made one investment, in NucleusCare, as part...
Anthiem Ventures
Anthiem Ventures is an angel investment firm that provides funding and guidance to early-stage companies. It has made one investment, in NucleusCare, as part of a Seed round on March 27, 2015.
General information
Firm type
Venture Capital
Year founded
2013
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
George Weinberger
Founder and Managing Partner
Frequently asked questions
How is Anthiem Ventures related to Datek Securities?
George Weinberger co-founded Datek Securities with Aaron Elbogen in the late 1980s. Datek was one of the pioneering electronic trading firms that helped retail investors access equity markets with reduced costs and faster execution, a model that presaged the online brokerage boom of the late 1990s. Anthiem is a separate investment vehicle, but Weinberger's operating background at Datek shapes the firm's willingness to invest in early-stage technology companies.
What real estate does Anthiem Ventures own?
Public records show Anthiem's principals own the 813 Quentin Road Medical Building in Brooklyn, a commercial property leased to medical tenants. The firm also participated in the bid process for Long Island Community Hospital (LICH) in Brooklyn, a major redevelopment site, though the outcome of that bid is not publicly confirmed.
What is George Weinberger's role at Maimonides Medical Center?
George Weinberger serves as Chairman of the board of Maimonides Medical Center, a major teaching hospital located in Borough Park, Brooklyn. This role connects him to healthcare operations and real estate demand in the Brooklyn market, which overlaps with Anthiem's ownership of the 813 Quentin Road Medical Building.
What investment stages does Anthiem Ventures target in venture capital?
Anthiem targets early-stage venture capital, including seed and startup rounds. No later-stage or growth-equity investments have been publicly identified, though the absence of disclosed portfolio companies limits a fuller understanding of check size and stage preferences.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: